Obesity (Silver Spring). Obesity accompanying COVID-19: the role of epicardial fat

[tetano]

Obesity (Silver Spring). 2020 May 4. doi: 10.1002/oby.22867. [Epub ahead of print]
Obesity accompanying COVID-19: the role of epicardial fat.


Zhao L[SUP]1[/SUP].

Author information




Abstract

With interest we read the study by Simonnet A et al. (1) in which important novel evidence is addressed that obesity is highly frequent among critically ill patients with severe acute respiratory syndrome coronavirus-2 (SARS-Cov-2) infection. Although clinically very relevant, it remains difficult to elucidate the mechanisms by which SARS-Cov-2 severity is increased in the context of obesity. As reported by Katz JN et al. (2), 28% of hospitalised patients with coronavirus disease 2019 (COVID-19) presented cardiac complications including myocarditis, arrhythmias, heart failure (HF) and sudden death. Considering that myocardial response in COVID-19 is closely associated with in-hospital mortality, local biological effects on myocardial tissue from epicardial adipose tissue (EAT) is warrant further discussion.
This article is protected by copyright. All rights reserved.



PMID:32365275DOI:10.1002/oby.22867

 

[tetano]

Obesity (Silver Spring). 2020 May 4. doi: 10.1002/oby.22866. [Epub ahead of print]
Obesity and severe COVID-19 disease: a strong association.


Samuels JD[SUP]1[/SUP].

Author information




Abstract

After having read your recent Editorial "COVID 19 and the Patient with Obesity - The Editors Speak Out"[SUP]1[/SUP] , I wish to share my own personal experience. I am an anesthesiologist working on the frontline of the coronavirus (SARS-CoV-2) pandemic at an academic and teaching establishment, Weill Cornell Medical College, New York-Presbyterian Hospital, in New York City. As Director of the Bariatric Anesthesia division, and an airway expert, I was assigned to our COVID Airway Team, in March 2020.
This article is protected by copyright. All rights reserved.



PMID:32365269DOI:10.1002/oby.22866